Focal adhesion kinase inhibitors, a heavy punch to cancer
Abstract Kinases are the ideal druggable targets for diseases and especially were highlighted on cancer therapy. Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase and its aberrant signaling extensively implicates in the progression of most cancer types, involving in cancer cell growth, a...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Springer
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/f8375424d64f46afbf8002a1c77b3cca |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|